5th Global Pharmacovigilance Summit

From Verify.Wiki
Jump to: navigation, search

 

History

Conference Series Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

With the grand success of Pharmacovigilance Series of Conferences in UK, USA in consecutive years over the last several years which met with great achievement in Business Conferencing. It’s glad to announce 8th Global Pharmacovigilance & Drug Safety Summit during July 6-7, 2017 in Kuala Lumpur, Malaysia with the theme “Innovations in Pharmacovigilance for Systematic safety and Management”. 8th Global Pharmacovigilance & Drug Safety Summit emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors.

The field of Pharmacovigilance is growing day by day and its development is marking high impact in fields of Pharmaceuticals and Medical Sciences. This conference creates a global platform to reach the largest assemblage of participants from various sectors to share their insights and convey recent developments in the field of Medicinal sciences, Health care and Drug Discovery involving Pharmacovigilance studies, Risk Management and Safety of Drug. This is a true forum where ideas and discussion is driven by the participants and interaction with peers and others leads to fruitful outcomes.

Theme

5th Global Pharmacovigilance Summit was held during April 28 - 29, 2016 in Dubai, which mainly focused on the advancements in Pharmacovigilance. Global Pharmacovigilance - 2016 emphasized on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. Main theme of Global Pharmacovigilance-2016 was “Ensure Safer Drugs to the Healthcare Community [1] The targeted Audience for this medical event for Pharmacovigilance Students, Scientists, Pharmacovigilance, researchers, and also members from Pharmacovigilance Faculty, Medical Colleges, Pharmacovigilance Associations and Societies. [2]

Why with us??? • 500 Open Access Journals • 50000 Editorial team • 50000 Reviewers team • 3.5 Million readers • Quality and quick editorial, review processing • 21 Days rapid review process • Publication within 7 days of acceptance

Conference Highlights :

  • Drug Safety, Adverse Drug Reactions, Pharmacovigilance Significance and Scope
  • Continental Pharmacovigilance, Good Pharmacovigilance Practice, Pharmacovigilance and Risk Management
  • Medical Devices Pharmacovigilance, Pharmacokinetics and Pharmacodynamics
  • Veterinary Pharmacovigilance, Pre-Clinical and Clinical Trials, Challenges in Pharmacovigilance
  • Clinical Trials on Various Disorders, Pharmacovigilance Market, Clinical Research and Statistics
  • Case Report in Clinical Trials, Biopharmaceutics, PV Data Base Management, PV Consultings and Bussiness

[3]

Track 1: Drug Safety

Concept of drug safety is also known as Medication Safety in the field of health. It is associated with adverse effects of Pharmaceutical products involving many other scientific aspects, such as the side effects of drugs, the quality of medications, medication error in usage of drugs, lack of efficacy of drugs, and counterfeit drugs. Patient Safety, Drug Interaction (drug–drug and food–drug interaction) Drug Pharmacokinetic, and Adverse Drug Reaction are several terms involved with Drug Safety. Companies have to conduct a complete drug safety and pharmacovigilance audit to gauge their compliance with international standards of laws, regulations, and guidance.

In this track we will be focusing on Drug Safety Updates, Drug Safety Solutions, Training, Surveillance, Services & Software, Reporting & Monitoring.

Related Drug Safety Events | Drug Safety Conferences | Pharmacovigilance Conferences

8th International Conference on Proteomics and Bioinformatics, May 22-24, 2017 Osaka, Japan ; Pharmacovigilance & RMS Summit June 6-7,2017, Washington, USA; 8th Asian Biosimilars Congress August 14-16, 2017 Osaka, Japan; Risk Mangement and Pharmacovigilance Summit 2017, September 12-14, 2017 Vienna; 19th International Conference on Biomarkers and Clinical Research September 7 - 8, 2017, Tokyo, Japan; Global Pharmaceutical Regulatory Affairs Summit October 24-26 2017, Prague; 9th Annual Congress on Drug Formulation & Drug Design, October 19-20, 2017 Seoul, South Korea; 16th Annual Medicinal & Pharmaceutical Sciences Congress October 19-20, 2017 Seoul, South Korea; 3rd International Conference on Transcriptomics, October 30 - November 01, 2017 Bangkok, Thailand ; 19th International Conference on Clinical Research Informatics, Management and Health Science, Kyoto, Japan; Pharmacovigilance Europe 2017, May 24-25 2017, London UK

Track 2: Adverse Drug Reactions

These reactions are an open challenge for Healthcare professionals -to understand the problem and be conscious of how these reactions can be prevented and managed. However, adverse drug reactions can be minimized including the patient as one pillar of the therapeutic plan and providing more patient counseling, which will improve drug safety.Assessing and reporting adverse drug reactions are very important to maintain drug safety systems. PK-PD studies are the two principal focus areas of pharmacology. Pharmacodynamics is the study of the molecular, biochemical, and physiological effects of drugs on cellular systems and site of action. Pharmacokinetics focuses on how the body affects the drug, in ADME terms. Today, Clinical Pharmacology techniques and pharmacologists use different techniques to explain and manipulate the pharmacological action for safer use health concerns.

Track 3: Clinical Research and Statistics

Pharmacovigilance is an important and integral part of clinical research and these days it is growing in many countries. Bioavailability and bioequivalence studies also plays major role in clinical research. Clinical trials are nothing but experiments done in clinical research. Clinical research system involves a complex network of pharmaceutical companies, sites and educational research institutions/ laboratories. Each clinical trial has a plan of action or a protocol for conducting trial. Clinical trials generate data on safety and efficacy.

Track 4: Pre-Clinical and Clinical Trials

The main goals of Pre-Clinical and Clinical Trials are to determine the safe dose and start to assess product's safety profile. Concentrating on dosages forms in random clinical trials is very important. Although preclinical studies have revealed many possible mechanisms for these Adverse Events, the causes of some adverse events remain unknown.

Discussions are encouraged on Preclinical and clinical trial mechanisms and their significance, improvements, adversity.

Track 5: Good Pharmacovigilance Practice:

Pharmacovigilance and Pharmacoepidemiology role in the risk management mainly focusses on to overcome insufficient evidence of safety from clinical trials. Good Pharmacovigilance Practice avoids major problems in risk management which are discussed in Pharmacovigilance Conferences. It is of high importance to focus on Signal investigation via observational studies and Interpreting safety signals. Concentrating on dosages forms in random clinical trials is very important. The Pharmacovigilance clinical trials service providing companies should have the Pharmacovigilance certification .[4]

The GLP is not satisfied without methods and procedures minimizing errors and maximizing accuracy and precision. So GLP is an essential part of GMP. Here according to this article I want to explain the problems of method used in clinical laboratory and analytical chemistry when constructing calibration STD Graphs (the equation of dilution) when preparing number of points run in arithmetic progression; which include increasing error possibility and shortage of stock STD and the avoidance of these errors by introducing new method APW arithmetic progression way in calibration STD curves or Hisham’s method in calibration STD Graphs which depends on the available volume; When preparing plenty number of points run in arithmetic progression manner. Furthermore it can be used to modify sensitive device to suck solution in arithmetic progression manner depending on difference and the available volume (A.P.W sucking devices).[5]

References

  1. https://www.facebook.com/events/1462599297399657/
  2. <https://www.emedevents.com/c/medical-conferences-2016/5th-global-pharmacovigilance-summit>
  3. <https://www.emedevents.com/c/medical-conferences-2016/5th-global-pharmacovigilance-summit>
  4. http://globalpharmacovigilance.pharmaceuticalconferences.com/2016/
  5. https://www.omicsgroup.org/journals/2329-6631/2329-6631.C1.014_010.pdf/

Verification history